BioRestorative Therapies, Inc. ("BRT" or the "Company")
(OTCBB:BRTX) , a life sciences company focused on adult stem
cell-based therapies for various personal medical applications, has
issued a letter to stockholders, the text of which is below.
ELMSFORD, N.Y. , July 23, 2014 /PRNewswire/ -- BioScrip ® , Inc. (NASDAQ: BIOS) announced today that the Company will release its 2014 second quarter financial results on Wednesday, August 6, 2014 , after the market closes.
ADVISORY, July 22, 2014 (GLOBE NEWSWIRE) -- What:
BioSpecifics Technologies Corp (Nasdaq:BSTC) , a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date, will visit the NASDAQ MarketSite in Times Square.
- Data suggest support for potential label expansion of XIAFLEX for Dupuytren's contracture to include treatment of two affected joints concurrently; PDUFA date is October 20, 2014 -
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting investment picks
Shareholder rights law firm Johnson & Weaver, LLP has commenced an
investigation into whether certain officers and directors of Biota
Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.